Filing Details

Accession Number:
0001293301-12-000050
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-12-07 15:55:04
Reporting Period:
2012-08-03
Filing Date:
2012-12-07
Accepted Time:
2012-12-07 15:55:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
38074 Forest Laboratories Inc FRX Pharmaceutical Preparations (2834) 111798614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509230 Jerome Lynch C/O Forest Laboratories, Inc.
909 Third Avenue
New York NY 10022
Svp-Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2012-08-03 646 $32.77 70,154 No 4 S Direct
Common Stock Disposition 2012-08-03 854 $32.76 69,300 No 4 S Direct
Common Stock Disposition 2012-12-05 1,988 $35.87 67,312 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 F Direct
Footnotes
  1. This amount includes shares of common stock which are subject to a risk of forfeiture.